Loading...
Market
Story
US Startup Offers $50,000 IQ Screening for 100 IVF Embryos Amid Ethical Concerns
Oct 18, 2024, 01:22 PM
A US startup has begun offering couples the ability to screen their IVF embryos for IQ, charging $50,000 to screen 100 embryos. This development follows the completion of the first-ever U.S. randomized controlled trial evaluating the impact of AI in embryo selection by Alife. The practice of polygenic embryo screening for desirable traits, including intelligence, has raised technological and ethical concerns among researchers. Japanese researchers have highlighted the questionable nature of this practice in a recent study.
View original story
Similar markets
Yes • 50%
No • 50%
Strongly Support • 25%
Somewhat Support • 25%
Somewhat Oppose • 25%
Strongly Oppose • 25%
More than 50% • 25%
25% to 50% • 25%
10% to 25% • 25%
Less than 10% • 25%
Majority support • 25%
Majority oppose • 25%
Evenly split • 25%
Unknown or unclear • 25%
Less than 40% • 25%
40% - 50% • 25%
51% - 60% • 25%
More than 60% • 25%
Strongly Support • 25%
Somewhat Support • 25%
Somewhat Oppose • 25%
Strongly Oppose • 25%
Effective • 25%
Ineffective • 25%
Neutral • 25%
No opinion • 25%
Strongly support • 25%
Somewhat support • 25%
Somewhat oppose • 25%
Strongly oppose • 25%
More support for stricter regulations • 25%
More support for current regulations • 25%
No significant change • 25%
Other • 25%
Majority agree • 25%
Majority disagree • 25%
Split opinion • 25%
No opinion • 25%
Mostly Positive • 25%
Mostly Negative • 25%
Mixed • 25%
Indifferent • 25%
Major backlash • 25%
Minor backlash • 25%
No significant reaction • 25%
Other • 25%